SCHEMBL7329793

SCHEMBL7329793

CCCC1C(=O)N(C(S)c2nnnn2-c2ccccc2)S(=O)(=O)N1C

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.38
ELANE P08246 6/20 0.37
LMNA P02545 4/20 0.35
SMN1; SMN2 Q16637 1/20 0.34
HSD17B10 Q99714 1/20 0.34
MAPT P10636 4/20 0.33
NPSR1 Q6W5P4 3/20 0.33
KMT2A Q03164 2/20 0.33
MEN1 O00255 1/20 0.33
TSHR P16473 1/20 0.33
HTT P42858 3/20 0.33
HPGD P15428 2/20 0.33
TP53 P04637 1/20 0.33
HSP90AA1 P07900 1/20 0.33
NLRP1 Q9C000 1/20 0.33
CYP3A4 P08684 1/20 0.32
CYP2D6 P10635 1/20 0.32
CYP2C19 P33261 1/20 0.32
CCR6 P51684 2/20 0.32
CACNA1B Q00975 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7328817 0.90 ALDH1A1 (0.38) ALDH1A1ELANELMNAMAPTNPSR1
SCHEMBL7337980 0.82 NPSR1 (0.36) ALDH1A1ELANELMNASMN1; SMN2MAPT
SCHEMBL7330906 0.80 ALDH1A1 (0.38) ALDH1A1ELANELMNASMN1; SMN2MAPT
SCHEMBL7329786 0.74 ELANE (0.54) ALDH1A1ELANEMAPTKMT2AMEN1
SCHEMBL7339821 0.72 ALDH1A1 (0.36) ALDH1A1LMNASMN1; SMN2MAPTNPSR1
SCHEMBL7304482 0.68 ELANE (0.52) ALDH1A1ELANENPSR1KMT2AMEN1
SCHEMBL7335115 0.66 ELANE (0.53) ALDH1A1ELANELMNASMN1; SMN2HSD17B10
SCHEMBL7328809 0.65 ELANE (0.53) ALDH1A1ELANEMAPTKMT2AMEN1
SCHEMBL8872235 0.65 ELANE (0.49) ALDH1A1ELANESMN1; SMN2NPSR1
SCHEMBL8870910 0.65 ELANE (0.40) ALDH1A1ELANE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5494925-A TREATING DEGENERATIVE DISORDERS; PROTEOLYTIC ENZYME INHIBITOR STERLING WINTHROP INC. (US) 1996-02-27 US claimed
EP-0793494-A4 2-HETEROCYCLYLOXY AND THIOMETHYL-1,2,5-THIADIAZOLIDIN-3-ONE 1,1-DIOXIDES AND COMPOSITIONS AND METHOD OF USE THEREOF SANOFI WINTHROP INC (US) 1998-01-28 EP disclosed
EP-0793494-A1 2-HETEROCYCLYLOXY AND THIOMETHYL-1,2,5-THIADIAZOLIDIN-3-ONE 1,1-DIOXIDES AND COMPOSITIONS AND METHOD OF USE THEREOF SANOFI WINTHROP, INC. (US) 1997-09-10 EP disclosed
WO-1996016649-A1 2-HETEROCYCLYLOXY AND THIOMETHYL-1,2,5-THIADIAZOLIDIN-3-ONE 1,1-DIOXIDES AND COMPOSITIONS AND METHOD OF USE THEREOF SANOFI WINTHROP, INC. (US) 1996-06-06 WO disclosed
US-5494925-A TREATING DEGENERATIVE DISORDERS; PROTEOLYTIC ENZYME INHIBITOR STERLING WINTHROP INC. (US) 1996-02-27 US disclosed